I am a Post-Doctoral Research Associate at the Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. My current research focuses on understanding the metabolic factors influencing lymphoma and leukemia dissemination. I earned my Ph.D. in Biomedical Sciences from the University of Macau with a fully funded Ph.D. scholarship, where I investigated the anti-metastatic and anti-angiogenic effects of Artemisinin in melanoma via modulation of the PI3K/AKT/mTOR signaling pathway. My research expertise includes cancer biology, autophagy, cancer metabolism, and angiogenesis, with extensive experience in both in vitro and in vivo models. Before joining Georgetown, I worked as a postdoctoral researcher at UTHealth Houston, exploring the role of autophagy in tumor progression. I have authored over 25 peer-reviewed publications in high-impact journals, including Medicinal Research Reviews, Oxidative Medicine and Cellular Longevity, Cells, and Advanced Drug Delivery Reviews. I have received multiple international travel awards in recognition of my scientific contributions and currently serve as an academic editor and advisory board member for several international journals. My long-term goal is to integrate cancer metabolism, autophagy, and immune regulation to develop novel therapeutic strategies for aggressive and therapy-resistant cancers
I am a Post-Doctoral Research Associate at the Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. My current research focuses on understanding the metabolic factors influencing lymphoma and leukemia dissemination. I earned my Ph.D. in Biomedical Sciences from the University of Macau with a fully funded Ph.D. scholarship, where I investigated the anti-metastatic and anti-angiogenic effects of Artemisinin in melanoma via modulation of the PI3K/AKT/mTOR signaling pathway. My research expertise includes cancer biology, autophagy, cancer metabolism, and angiogenesis, with extensive experience in both in vitro and in vivo models. Before joining Georgetown, I worked as a postdoctoral researcher at UTHealth Houston, exploring the role of autophagy in tumor progression. I have authored over 25 peer-reviewed publications in high-impact journals, including Medicinal Research Reviews, Oxidative Medicine and Cellular Longevity, Cells, and Advanced Drug Delivery Reviews. I have received multiple international travel awards in recognition of my scientific contributions and currently serve as an academic editor and advisory board member for several international journals. My long-term goal is to integrate cancer metabolism, autophagy, and immune regulation to develop novel therapeutic strategies for aggressive and therapy-resistant cancers